This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
(Bloomberg) -- Standing high on top of a windswept dune in the West Texas plains, Greg Edwards stares out into a vast ocean of sand. It stretches in every direction, interrupted only by an occasional strip of asphalt or clusters of silos that rise high into the sky.
EMES JEF HCLP
HOUSTON (Bloomberg) -- Standing high on top of a windswept dune in the West Texas plains, Greg Edwards stares out into a vast ocean of sand. It stretches in every direction, interrupted only by an occasional strip of asphalt or clusters of silos that rise high into the sky.
RTPPF RIO RIO RIO RTNTF EMES JEF HCLP
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
RTPPF RIO RIO RIO RTNTF EMES JEF HCLP
Core Laboratories N.V.’s (CLB - Free Report) shares declined more than 13.5% to eventually close at $112.66 on Jul 2, after the company downwardly revised its second-quarter 2018 outlook amid deferred international activities. In its first-quarter report, the company forecast second-quarter earnings of around 64-68 cents per share. However, a delay in the recovery of international oilfield development activities has compelled the company to cut its guidance.
ABX CHOLY EMES AROC 2883 CHOLF CLB ABX
Emerge Energy Services LP (EMES - Free Report) recently announced plans to expand its in-basin sand operations with a new mining and processing facility, which is located in the Kingfisher County, OK. Superior Silica Sands, a unit of Emerge Energy, inked a 25-year lease deal to receive the mining rights for 600 acres, which is located around 60 miles (96.6 kilometers) northwest of the Oklahoma city.
APC DK HFC EMES AEUA
Select Energy Services, Inc. is a unique growth company with no other direct comparables. If you are invested in fracking or Permian-related stocks, this is a must-read article.
APA XOM DVN WTTR PE HCLP COP EMES JAG BCDTY FRAC SLB LBRT VNOM FTSI BSC EOG BHI PTEN GRR CVX PUMP SLB SND TTI OXY FANG
Document Table of Contents
Frac sand MLPs Hi-Crush Partners (HCLP) and Emerge Energy Services (EMES) reported their 1Q18 results on May 1. Hi-Crush Partners’ adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) rose from $59 million in 4Q17 to $64.5 million, and its distributable cash flow rose to $56.4 million from $52 million. Extreme winter and railroad issues impacted the company’s performance during the quarter.
Apache Corporation (APA - Free Report) is expected to beat expectations in first-quarter 2018 results, when it releases earnings on May 2, after the market closes. The current Zacks Consensus Estimate for the quarter under review is a profit of 27 cents on revenues of $1,640 million.
APA CNA CRK EMES PBA
2018-07-13 - Asif
Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...
2018-07-09 - Asif
Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...
2018-07-06 - Asif
Overview Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company's proprietary paresthesia-free HF10TM therapy, delivered by its Senza system, was demonstrated in its SENZA-RCT study to be superior to traditional SCS therapy with it being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy. Comparatively, traditional SCS therapy has limited efficacy in treating back pain and is used primarily for treating leg pain, limiting its market adoption. The company's SENZA-RCT study, along with its European studies, represents what the company believe is the most robust body of clinical evidence for any SCS therapy. The compa...
Silicon Investor Message Boards
This table lists all message boards related to EMES / Emerge Energy Services LP on message board site Silicon Investor.
|THEM (THEMESCAPES.INC.) INTERNET E-COMMERCE||Bioanalytical Systemes (BASI)|
as of ET